Trial0

Clinical trial · NCT07239609

ACT for Individuals With MNCD and Their Care Partners

RecruitingPhase 1

Sponsor: Texas Tech University

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

This project aims to implement and evaluate a dyadic intervention (i.e., acceptance commitment therapy) for persons with AD/ADRD and their care partners. We hypothesize the intervention will be feasible, acceptable, and show preliminary efficacy of the dyadic interveniotns.

Interventions

  • Acceptance Commitment Therapy · BEHAVIORAL

    Acceptance and Commitment Therapy (ACT) is a form of cognitive-behavioral therapy that aims to enhance psychological flexibility through six core processes: acceptance, cognitive defusion, being present, self-as-context, values clarification, and committed action. Rather than attempting to eliminate difficult thoughts and feelings, ACT encourages individuals to accept them while committing to behavior changes consistent with their personal values.

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria

Inclusion (person with MCI or MNCD):

* 18+
* MMSE= 21-27
* Able to communicate in English

Inclusion (care partner):

* 18+
* Identifies as a care partner of a person with MNCD
* Able to communicate in English
* MMSE= 28-30
* Is a family member or friend of the person with MNCD

Exclusion Criteria

Exclusion (person with MCI or MNCD):

* Currently in an intervention for reducing anxiety or depression related to their dementia
* MMSE= 28+ or less than 21

Exclusion (care partner):

* MMSE= \<28
* Is a formal (paid) caregiver

Sites (1)

  • Texas Tech University Plaza Building, Lubbock, Texas · Recruiting

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2026-05-15.